Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
<p><strong>Background</strong></p> <p>Asthma affects 350 million people worldwide including 45% to 70% with mild disease. Treatment is mainly with inhalers containing beta₂‐agonists, typically taken as required to relieve bronchospasm, and inhaled corticosteroids (ICS)...
主要な著者: | Crossingham, I, Turner, S, Ramakrishnan, S, Fries, A, Gowell, M, Yasmin, F, Richardson, R, Webb, P, O'Boyle, E, Hinks, TSC |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Wiley
2021
|
類似資料
-
Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
著者:: Crossingham, I, 等
出版事項: (2020) -
Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review
著者:: Crossingham, I, 等
出版事項: (2021) -
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST)
著者:: Howell, I, 等
出版事項: (2023) -
A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)
著者:: Couillard, S, 等
出版事項: (2021) -
Azithromycin for mild-to-moderate COVID-19 - Authors' reply
著者:: Hinks, TSC
出版事項: (2021)